TrialInternational journal of cancer2022

A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma.

Jung Hyun Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.